One solution is to import generic drugs from countries such as India, which does a thriving trade in copy-cat pharmaceuticals because it is not yet obliged to recognise drug patents.

ECONOMIST: Patently troublesome

Xalatan eye solution recently lost market exclusivity in major countries, clearing the way for cheaper generic copies.

WSJ: New Drug Approved to Treat Eye Condition